INTRA-OP
- SCDs and TED hose placed on patient prior to induction
FOR NEUROMONITORING CASES:
TIVA
BIS Monitoring
INDUCTION
- Goal: No opioid administration
Esmolol 0.5 mg/kg IV for post-intubation hypertension/tachycardia
Ketamine 0.25 mg/kg IBW IV bolus at induction
Lidocaine 100 mg IV bolus at induction
Lidocaine infusion (begin after bolus): 2 mg/kg/hr IBW ON PUMP β discontinue at end of case. (Contraindications: profound liver disease, recent MI < 6 mths, seizure disorder, 2nd or 3rd degree heart block, WPW)
PRIOR TO INCISION
Antibiotic prophylaxis:
COH protocol
Dexamethasone 10 mg IV
Phenylephrine PRN hypotension: DRIPS MUST BE ON PUMP
TXA 1 gram (Note: COH exclusion criteria)
Maintain normothermia
- Goal Directed Fluid Therapy using NICOM
Document SV, CI, SVV prior to positioning
Follow SV optimization protocol throughout case
Document SV, CI Q 1hr and if SV β by 10%, indicating a 250 mL fluid bolus
LR fluid bolus x2, then use 5% albumin
AFTER INCISION
- Goal Directed Fluid Therapy
Use NICOM and GDFT algorithm throughout case β SV optimization
Maintain normothermia β utilize WARM fluids
- Blood glucose monitoring:
For all diabetic patients, continue PAA glycemic control order set
Check FSBS Q 1hr
For all non-diabetic patients, check FSBG within 60 min after induction
Goal blood glucose: 100-180 mg/dl
Check FSBG Q 2hr
If FSBG >180, initiate PAA glycemic control order set
- Goal: NO intraoperative opioid
Esmolol 0.5mg/kg IV for tachycardia/hypertension
Ketamine 0.25 mg/kg Q1 hr for a total max dose of 2mg/kg
Precedex 0.25 mcg/kg IV Bolus PRN: Max dose 2mcg/kg OR Precedex 0.25 mcg/kg/hr infusion ON PUMP
Check Hgb if EBL >1000 mL or labile hemodynamics
END OF CASE
Ofirmev 1 g IV (**IF NOT GIVEN IN PREOP**) towards end of case
If patient has a Sulfa allergy and did not get preop Celebrex, then Ketorolac 15 mg IV
At emergence: Ondansetron 4 mg IV
Confirm ALL fluids both input and output are documented